China’s drug regulator has accepted Novo Nordisk’s application to sell an oral version of its Wegovy weight-loss drug, according to a Reuters report published on August 27. The regulatory filing in the world’s second-largest pharmaceutical market marks a step for the Danish drugmaker as it chases rival Eli Lilly in the burgeoning anti-obesity sector. Regulatory … Read more
According to Reuters reporting from Kyiv, ousted Defence Minister Mykhailo Fedorov warned that Ukraine is gradually losing the war against Russia, citing a shrinking window of several months to reverse course through institutional reform, technological innovation, and new military strategy. Fedorov’s public assessment starkly contrasts with official government rhetoric. Reform and Strategy Divisions According to … Read more
Unitree shares slumped 45% from their debut peak in late August, dropping by $30 billion after soaring to an early $66 billion valuation on the Shanghai STAR Market, according to Reuters. The steep post-listing selloff for China’s best-known humanoid robot maker has triggered widespread regulatory and investor anxiety over retail losses, retail trading frenzies, and … Read more
To help secure billions of dollars for his insurance firms, billionaire Mark Walter proposed using his equity holdings in Guggenheim Partners as collateral, a Bloomberg News story published on Thursday revealed. The capital-raising push involves offering double-digit yields to lenders for Walter’s TWG holding company, as reported by Bloomberg News. Debt Restructuring at Delaware Life … Read more
Wall Street closed lower as climbing crude oil prices driven by Middle East tensions and a massive share sale by Intel weighed on investor sentiment, according to Reuters. The S&P 500 declined 0.06% to finish at 7,753.12 points, while the tech-heavy Nasdaq Composite dropped 0.32% to 26,605.36 points, and the Dow Jones Industrial Average slipped … Read more